Comparative effectiveness of inebilizumab versus conventional immunotherapies in AQP4-IgG-positive NMOSD: a prospective cohort study with time-varying treatment effects.

Rituxan (rituximab) - Roche

azathioprine - Generic mfg.

mycophenolate mofetil - Generic mfg.

Uplizna (inebilizumab-cdon) - Amgen

http://www.ncbi.nlm.nih.gov/pubmed/42744600

Chao Quan; Hongmei Tan; Jingzi ZhangBao; Lei Zhou; Qiang Dong; Wenjuan Huang; Xiang Li; Xintong Zhang; Zhouzhou Wang

Sep 16, 2026